A comparative study of the safety, tolerability, and efficacy of cefdinir and cephalexin for the treatment of subjects with mild to moderate uncomplicated skin and skin structure infections

Trial Profile

A comparative study of the safety, tolerability, and efficacy of cefdinir and cephalexin for the treatment of subjects with mild to moderate uncomplicated skin and skin structure infections

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Oct 2007

At a glance

  • Drugs Cefalexin; Cefdinir
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 26 Oct 2007 Status changed from in progress to completed
    • 26 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top